Amgen Inc. (NASDAQ:AMGN) Q2 2019 Earnings Conference Call July 30, 2019 5:30 PM ET Amgen Inc.（纳斯达克股票代码：[AMGN]）2019年第二季度收益电话会议2019年7月30日美国东部时间下午5:30 公司参与者 Arvind Sood - Vice President, Investor Relations Bob Bradway - Chairman & Chief Executive Officer David Meline - Chief Financial Officer Murdo Gordon - Head of Global Commercial Operations David Reese - Head of R&D Arvind Sood - 投资者关系副总裁 Bob Bradway - 董事长兼首席执行官 David Meline - 首席财务官 Murdo Gordon - 全...

Amgen Inc. (NASDAQ:AMGN) Goldman Sachs 40th Annual Global Healthcare Conference June 12, 2019 2:20 PM ET Amgen Inc.（纳斯达克股票代码：[AMGN]）Goldman Sachs第40届全球医疗保健会议2019年6月12日美国东部时间下午2:20 公司参与者 David Reese - Executive Vice President of R&D David Reese - 研发执行副总裁 电话会议参与者 Terence Flynn - Goldman Sachs Terence Flynn - 高盛 特伦斯·弗林 Okay, great. I think we are going to get started. Thanks for joining us for our session with Amgen. I am Terence Flynn, and I am the ...

Amgen Inc. (NASDAQ:AMGN) Investor Event at ASCO 2019 June 3, 2019 7:30 PM ET Amgen Inc.（纳斯达克股票代码：[AMGN]）ASCO 2019年6月3日美国东部时间下午7:30举行的投资者活动 公司参与者 Arvind Sood - Vice President of Investor Relations Marwan Fakih - Professor, Department of Medical Oncology and Therapeutics Research Greg Friberg - Head of Oncology Global Development, Amgen, Inc. Ramaswamy Govindan - Professor, Department of Medicine Oncology Division, WUSM Arvind Sood - 投资者关系副总裁 Marwan Fakih - 医学肿瘤学和治疗学研究系教...